12 Feb Hospital 12 de Octubre actively recruiting in TRANSBIO clinical study
On October 2018, the Ethical Committee of the Hospital 12 de Octubre (Madrid) approved the inclusion of the hospital in the TRANSBIO clinical study and the Site Initiation Visit was performed on December 2018. Since then, 7 patients have been recruited.
The 9 centres involved in the TRANSBIO clinical study, based in 5 different countries (Spain, Germany, Polonia, Denmark and the USA), are actively recruiting in the planned rate, with a total of 179 patients enrolled to date.
With the 200 patients target sample size, we expect to confirm the robustness, reliability and clinical consistency of IMMUNOBIOGRAM® as an in vitro test to adjust immunosuppressive therapy in a personalized way in patients with kidney transplantation.